All News

Every pharmacist can make a difference in patients’ lives by taking the time to understand and fulfill the community’s social and cultural needs.

The phase 3 S1826 trial is the largest Hodgkin lymphoma study in NCTN history.

Chemotherapy may increase inflammatory biomarkers that can impact the diversity of the gut microbiome, leading to serious anthropomorphic changes among women treated for early-stage breast cancer.

Identification is key: this silent disease can lead to complications.

Findings indicate that the supplements improved white blood cell and platelet alterations while improving the inflammatory profile during high-intensity interval training.

A panel at the Advanced Topics for Oncology Pharmacy Professionals Summit discusses strategies to address patients’ fears and distrust of the medical and scientific community.

Effective implementation of the Inflation Reduction Act may allow legislators to shift their focus toward controversial pharmacy benefit manager practices, according to a panel discussion during the ATOPP Summit.

A cancer vaccine has shown efficacy in dogs, with implications for benefit in humans.

Tooth loss and gum disease may play a role in the health of the brain area that controls thinking and memory.

Despite a slew of barriers with patient management, pharmacists have the training and resources to advocate for better patient care and help patients with hematologic myeloproliferative neoplasms advocate for themselves.

Drug shortages have led to increased use of compounding pharmacy.

Study among the first to examine delayed or missed pediatric preventative care during COVID-19 that considers determinants, race, and ethnic group, according to the authors.

Quality standards and national regulation help to establish its role as medicine.

The practice has biologic, epigenetic, and structural implications on people living in these once-segregated areas.

Proof-of-concept device will be able to detect SARS-CoV-2 within minutes.

The approval makes remdesivir the first and only approved antiviral treatment for patients across all stages of renal disease.

Data show these cases pose some of the most significant threats to patients and health systems.

The effectiveness of influenza vaccines varies each season and is determined by the circulating influenza virus subtype(s) and the extent to which there is an antigenic match in the vaccines to the circulating virus subtypes.

Because of its prevalence in approximately 50% of breast cancers, the outcomes of HER2-low treatment have a significant impact on patient outcomes.

David Keene, vice president of Digital Therapeutics at atai Life Sciences, discussed the growth and future of digital therapeutics.

Updated phase 3 trial data provide practice-changing findings.

Expanding pharmacist–patient care services to include vaccine promotion and administration within ambulatory clinics is an example of the expanding role of pharmacists and their contribution to primary care practice.

These study results may inform clinical practice strategies this year and beyond.

Chronic or recurring episodes can lead to other complications.

Irreversible Bruton tyrosine kinase inhibitor produces positive results in patients with relapsed/refractory marginal zone lymphoma.

Evidence remains limited for specific therapies to treat the disease, but new clinical trials are ongoing.

A potential new drug therapy found from blood proteins could improve outcomes for individuals diagnosed with long COVID.

Impact of healthy eating was especially evident in countries where consumption of these foods is low, which elevates the risk for cardiovascular disease, including heart attacks and strokes.